Antioxidant and inflammatory biomarkers for the identification of prodromal Parkinson's disease

Reduced systemic antioxidant capacity is found in prodromal and overt PD and may represent, in association with olfactory loss and cardiovascular dysautonomia, a useful biomarker for an integrative, early diagnosis of PD.